Lisinopril vs Upadacitinib
Lisinopril vs Upadacitinib: Overview
This comparison examines the pharmacological differences between Lisinopril and Upadacitinib.
Mechanism of Action
Lisinopril: ACE inhibitor preventing conversion of angiotensin I to angiotensin II.
Upadacitinib: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.
Pharmacokinetics
Half-life: Lisinopril β 12 hours; Upadacitinib β 9-14 hours.
Chemical Properties
Molecular Formula: Lisinopril β C21H31N3O5; Upadacitinib β C17H19F3N6O.
Molecular Weight: Lisinopril β 405.4900 g/mol; Upadacitinib β 380.3700 g/mol.
Type: Lisinopril β Small molecule; Upadacitinib β Small molecule.